Wong Ryan Ho-Yan 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Wong Ryan Ho-Yan
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-03-02$16.20/sh−450$7,290→ 135,595 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ryan Ho-Yan Wong|2026-03-03